Levosimendan, a novel myofilament calcium sensitizer, allows weaning of parenteral inotropic therapy in patients with severe congestive heart failure

Autor: Hosenpud, Jeffrey D. *
Zdroj: In The American Journal of Cardiology 1999 83(12) Supplement 2:9-11
Databáze: ScienceDirect